scholarly journals Central Nervous System Toxoplasmosis and Cytomegalovirus Colitis in an Asymptomatic HIV Positive Patient

Cureus ◽  
2021 ◽  
Author(s):  
Bernard O Emuze ◽  
Molly S Jain ◽  
Enkhmaa Luvsannyam ◽  
Paro Bhaya ◽  
Carlos Vaquero
2021 ◽  
Vol 14 (3) ◽  
pp. e237456
Author(s):  
Jasmine Pearce ◽  
Ray Sheridan ◽  
Johnathan Shaw ◽  
Thomas Senior

This case demonstrates an atypical radiological presentation of cerebral toxoplasmosis in a 62-year-old HIV-positive patient. The diagnosis is discussed alongside MRI imaging, laboratory results and treatment. Central nervous system toxoplasmosis is typically associated with ring enhancing lesions on neuroimaging with contrast, but the radiology for this patient shows diffuse white matter changes and ependymal enhancement, which would normally suggest an alternative diagnosis.


Author(s):  
Carlos Tavares Bello ◽  
Francisco Sousa Santos ◽  
João Sequeira Duarte ◽  
Carlos Vasconcelos

Summary Central diabetes insipidus (DI) is a rare clinical entity characterized by low circulating levels of antidiuretic hormone (ADH) presenting with polyuria and volume depletion. Pituitary surgery is the most common cause of central DI in adults. Pituitary and hypothalamic disease, particularly invasive neoplasms, rarely cause DI, being idiopathic cases responsible for the majority of non-surgical cases. HIV patients, especially those with poor virulogical control, are prone to the development of CNS neoplasms, particularly lymphomas. These neoplasms usually become manifest with mass effects and seizures. Central DI and hypopituitarism are uncommon initial manifestations of primary CNS lymphomas. The authors describe the case of 29-year-old female, HIV-positive patient whose CNS lymphoma presented with DI. Learning points: Central diabetes insipidus has multiple causes and central nervous system lymphomas are not often considered in the differential diagnosis due to their low prevalence. Accurate biochemical diagnosis should always be followed by etiological investigation. The HIV population is at risk for many neoplasms, especially CNS lymphomas. New-onset polyuria in an HIV-positive patient in the absence of focal neurological signs should raise the suspicion for a central nervous system process of neoplastic nature. This clinical entity usually constitutes a therapeutical challenge, often requiring a multidisciplinary approach for optimal outcome.


2016 ◽  
Vol 145 (2) ◽  
pp. 258-265 ◽  
Author(s):  
Ali Nael ◽  
Vighnesh Walavalkar ◽  
William Wu ◽  
Kambiz Nael ◽  
Ronald Kim ◽  
...  

2009 ◽  
Vol 59 (1) ◽  
pp. 59-60 ◽  
Author(s):  
S. Cantoni ◽  
P. G. Oreste ◽  
A. M. Nosari ◽  
C. Schiantarelli ◽  
M. Caroli Costantini ◽  
...  

1992 ◽  
Vol 239 (8) ◽  
pp. 469-470 ◽  
Author(s):  
Elizabeth Sinclair ◽  
Fran�oise Gray ◽  
Francesco Scaravilli

2018 ◽  
Author(s):  
T Lupia ◽  
MG Milia ◽  
C Atzori ◽  
S Audagnotto ◽  
D Imperiale ◽  
...  

AbstractEpstein-Barr virus (EBV) often accesses the central nervous system (CNS) where it may lead to blood brain barrier (BBB) integrity disruption, facilitating the migration of immune cells into brain parenchyma. Our aim was to study the association between cerebrospinal fluid (CSF) EBV DNA and HIV-1 compartmental replication. 281 HIV-positive adults undergoing lumbar punctures for clinical reasons (excluding those with lymphoproliferative disorders) and CSF samples were examined. CSF virological, neurodamage (tau, p-tau, 1-42 beta amyloid) and immune activation (neopterin and S100beta) markers were measured by immune-enzymatic, ELISA and PCR validated methods. Two hundred eighty one patients were included; 111 (40.5 %) were naïve for antiretroviral treatment. CSF EBV DNA was detectable in 25 (21.9%) naïve and 26 (16%) treated patients at low levels (<100 and 146 copies/mL). Naïve EBV+ subjects presented higher CSF HIV RNA, biomarkers (t-tau, p-tau, neopterin) and higher rates of pleocytosis. Treated EBV+ individuals showed pleocytosis, higher CSF HIV RNA, CSF to serum albumin ratio, IgG index and neopterin. No association was observed between detectable CSF EBV DNA and the rate of CSF escape. In patients with plasma HIV RNA <20 copies/mL (n=97) CSF EBV DNA was detectable in 13 subjects (13.4%) and it was associated with pleocytosis, higher CSF HIV RNA and neopterin levels. EBV DNA was detectable in a considerable proportion of HIV-positive patients and it was associated with higher levels of CSF HIV RNA and neuronal damage/inflammation biomarkers. The role of EBV reactivation in HIV-associated CNS disorders warrant further studies.ImportanceEBV is a human gamma-herpesvirus with a seroprevalence in adults approaches 95% and the pattern of clinical manifestations is very heterogeneous and varies from asymptomatic or mild viral infection to a tightly linked with several malignancies as nasopharyngeal carcinoma, Hodgkin’s lymphoma and Burkitt’s lymphoma. HIV-infected and immunocompetent patients were both at risk of primary infection and complications linked to EBV.Primary tropism of EBV is for lymphocytes (type B, T and NK), epithelial, endothelial and smooth muscle cells and establishes lifelong latent infection. Central nervous system could be affected by this herpesvirus in primary infection and reactivation and EBV-DNA is not an uncommon finding in CSF in HIV-infected population. The significance of our research is in identifying the presence of a link between HIV and EBV CNS replication.


2014 ◽  
Vol 15 (3) ◽  
pp. 81-96 ◽  
Author(s):  
R Nassen ◽  
K Donald ◽  
K Walker ◽  
S Paruk ◽  
M Vujovic ◽  
...  

HIV-positive children and adolescents are at increased risk of both central nervous system (CNS) sequelae and mental disorders owing to a number of factors, including the impact of HIV infection on the brain, social determinants of health (e.g. poverty and orphanhood) and psychosocial stressors related to living with HIV. Every effort should be made to identify perinatally HIV-infected children and initiate them on antiretroviral therapy early in life. HIV clinicians should ideally screen for mental health and neurocognitive problems, as part of the routine monitoring of children attending antiretroviral clinics. This guideline is intended as a reference tool for HIV clinicians to support the early identification, screening and management of mental health disorders and/or CNS impairment in children and adolescents. This guideline covers mental disorders (section 1) and HIV-associated neurocognitive disorders (section 2) among children and adolescents.  


Sign in / Sign up

Export Citation Format

Share Document